Pancreatic Disorders

Top Story

UT Southwestern appoints chair of surgery department

April 21, 2018

‘Window of opportunity’ exists for durvalumab as pancreatic cancer maintenance therapy

March 19, 2018
A randomized clinical trial is underway to assess the efficacy of the novel immunotherapy durvalumab as maintenance therapy for patients with pancreatic cancer. Gentry

Anthera halts development of EPI drug candidate Sollpura

March 13, 2018
Anthera Pharmaceuticals announced it will discontinue the development of Sollpura after the drug failed to meet the primary endpoint of a phase 3 trial. Sollpura…

Boston Scientific acquires EMcision, expands endoscopy portfolio

March 8, 2018
Boston Scientific announced that it has acquired EMcision, a company based in the United Kingdom and Canada. The acquisition includes the Habib EndoHPB probe, a novel…
More Headlines »